These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2075750)

  • 1. Gastric retention and delayed absorption of a large dose of butylated hydroxytoluene in the rat.
    Takahashi O
    Xenobiotica; 1990 Dec; 20(12):1319-29. PubMed ID: 2075750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
    Thompson JA; Malkinson AM; Wand MD; Mastovich SL; Mead EW; Schullek KM; Laudenschlager WG
    Drug Metab Dispos; 1987; 15(6):833-40. PubMed ID: 2893710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of butylated hydroxytoluene to toxic metabolites. Factors influencing hydroxylation and quinone methide formation by hepatic and pulmonary microsomes.
    Bolton JL; Thompson JA
    Drug Metab Dispos; 1991; 19(2):467-72. PubMed ID: 1676656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT quinone methide) in the metabolism of butylated hydroxytoluene.
    Takahashi O; Hiraga K
    Food Chem Toxicol; 1983 Jun; 21(3):279-83. PubMed ID: 6683224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical visualization and identification of rat liver proteins adducted by 2,6-di-tert-butyl-4-methylphenol (BHT).
    Reed M; Thompson DC
    Chem Res Toxicol; 1997 Oct; 10(10):1109-17. PubMed ID: 9348433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation and reactivity of alternative quinone methides from butylated hydroxytoluene: possible explanation for species-specific pneumotoxicity.
    Bolton JL; Sevestre H; Ibe BO; Thompson JA
    Chem Res Toxicol; 1990; 3(1):65-70. PubMed ID: 2131827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in blood coagulation factors II (prothrombin), VII, IX and X in the rat after a single oral dose of butylated hydroxytoluene.
    Takahashi O
    Food Chem Toxicol; 1987 Mar; 25(3):219-24. PubMed ID: 3570109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of butylated hydroxyanisole, butylated hydroxytoluene, and NaCl on gastric carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine in F344 rats.
    Shirai T; Fukushima S; Ohshima M; Masuda A; Ito N
    J Natl Cancer Inst; 1984 May; 72(5):1189-98. PubMed ID: 6585594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of reactive intermediates from the tumor promoter butylated hydroxytoluene hydroperoxide in isolated murine keratinocytes or by hematin.
    Taffe BG; Zweier JL; Pannell LK; Kensler TW
    Carcinogenesis; 1989 Jul; 10(7):1261-8. PubMed ID: 2472232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT quinone methide): an active metabolite of BHT causing haemorrhages in rats.
    Takahashi O
    Arch Toxicol; 1988; 62(4):325-7. PubMed ID: 3240097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of single oral doses of butylated hydroxytoluene in man and rat.
    Verhagen H; Beckers HH; Comuth PA; Maas LM; ten Hoor F; Henderson PT; Kleinjans JC
    Food Chem Toxicol; 1989 Dec; 27(12):765-72. PubMed ID: 2606406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced lung toxicity of butylated hydroxytoluene in mice by coadministration of butylated hydroxyanisole.
    Yamamoto K; Tajima K; Okino N; Mizutani T
    Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):219-31. PubMed ID: 3358012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of a glutathione conjugate from butylated hydroxytoluene by rat liver microsomes.
    Tajima K; Yamamoto K; Mizutani T
    Biochem Pharmacol; 1985 Jun; 34(12):2109-14. PubMed ID: 4004928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the peroxidase-mediated oxidation of butylated hydroxytoluene to a quinone methide by phenolic and amine compounds.
    Thompson DC; Trush MA
    Chem Biol Interact; 1989; 72(1-2):157-73. PubMed ID: 2510948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene.
    Maeura Y; Weisburger JH; Williams GM
    Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotope effects on the metabolism and pulmonary toxicity of butylated hydroxytoluene in mice by deuteration of the 4-methyl group.
    Mizutani T; Yamamoto K; Tajima K
    Toxicol Appl Pharmacol; 1983 Jun; 69(2):283-90. PubMed ID: 6868090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of butylated hydroxytoluene by mouse bronchiolar Clara cells.
    Bolton JL; Thompson JA; Allentoff AJ; Miley FB; Malkinson AM
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):43-9. PubMed ID: 8236260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.